Immunoglobulins Anti Platelets In Breast Milk Of Maternal ITP
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01880801|
Recruitment Status : Unknown
Verified February 2012 by Laniado Hospital.
Recruitment status was: Not yet recruiting
First Posted : June 19, 2013
Last Update Posted : June 19, 2013
The purpose of this study is to determine whether mothers with Idiopathic thrombocytopenic purpura (ITP) has antibodies against platelets in breastfeeding milk aside control group of healthy mothers.
In order to prevent severe thrombocytopenia in infants born to mothers with ITP.
|Condition or disease|
|Mothers With ITP Condition|
|Study Type :||Observational|
|Estimated Enrollment :||22 participants|
|Official Title:||IMMUNOGLOBULINS ANTI PLATELETS IN BREAST MILK OF MATERNAL ITP|
|Study Start Date :||August 2013|
|Estimated Primary Completion Date :||August 2014|
|Estimated Study Completion Date :||August 2014|
- IMMUNOGLOBULINS ANTI PLAITLETS IN BREST MILK OF MATERNAL ITP [ Time Frame: 4 times in the first month after delivery ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01880801
|Sharon Nechama, Laniado Hospital||Not yet recruiting|
|Contact: Nechama Sharone, MD 972-544303356 firstname.lastname@example.org|
|Principal Investigator: Nechama Sharon, MD|